Ms. Jennifer Donato, LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 116 Philadelphia Ave, Point Pleasant Beach, NJ 08742 Phone: 908-723-5551 |
Mrs. Patricia F Cooke, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 302 Hawthorne Ave, Point Pleasant Beach, NJ 08742 Phone: 848-210-3964 |
Dr. Francis Thomas Crawley Jr., EDD Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1101 Richmond Ave, Suite 104, Point Pleasant Beach, NJ 08742 Phone: 732-449-7833 Fax: 732-295-2280 |
Thomas H Jordan Jr., LCADC - NJ Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 302 Hawthorne Ave, Point Pleasant Beach, NJ 08742 Phone: 732-899-1511 Fax: 732-892-0984 |
Frank Adao Counselor Medicare: Not Enrolled in Medicare Practice Location: 214 Ocean Ave Unit 1, Point Pleasant Beach, NJ 08742 Phone: 732-948-4097 |
Kelly Ketcham, MA, LAC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 516 Bay Ave Ste 3, Point Pleasant Beach, NJ 08742 Phone: 848-235-9290 |
News Archive
Leica Microsystems and TrueVision® 3D Surgical announced the debut of 3D surgical microscopes at the 81st Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS).
Alzheimer's disease can reach epidemic range in the coming decades, by the increasing average age of society. There are two key issues for Alzheimer's disease: there is currently no effective treatment and it has been described very few associated genetic changes (mutations) which reduces the number of targets for future therapies.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
Kessler Foundation is the recipient of a MS Research Center Award from the National Multiple Sclerosis Society. John DeLuca, PhD, is principal investigator for the five-year $821,000 grant, which will fund the MS Collaborative Network of New Jersey. The MSCNNJ will bring together the Foundation's experts in mobility and cognitive research to advance understanding of cognitive-motor interaction in MS. Dr. DeLuca is Senior Vice President of Research and Training at the Foundation.
Researchers have found that resilient, altruistic, and straightforward individuals are significantly more likely to respond to a sham painkilling or placebo injection than those who are angry and hostile.
› Verified 9 days ago